Heather Cook and Robert Harris join the ranks
Health tech company, HN, which provides AI guided case-finding, remote monitoring, clinical coaching, and virtual ward solutions to the NHS, has bolstered its specialist advisory board with the addition of two new members.
Heather Cook, one of the UK’s leading digital health innovation and scale-up experts, has joined HN; along with Robert Harris, an experienced chairman, non-executive director and chief executive in the digital health, medical technology, and life science sectors.
And Wendy Saviour, who joined the advisory board in 2020, will be stepping down from her position.
HN provides innovative AI and data-driven healthcare solutions, including case finding of patients at risk of unplanned care, clinical coaching, and virtual ward solutions.
The company has experienced significant growth in recent years, largely accelerated due to the increase in demand for its case findings and remote support model.
HN founder, Dr Joachim Werr, and chief executive, Mark England, have both been adopted to the NHS Innovation Accelerator programme, supporting evidence-based solutions with high demand and need within the NHS.
And the company’s advisory board comprises of specialists from across the digital health industry boasting a wealth of experience and expertise.
Cook’s recent experience includes successfully building the brand of Brain in Hand, a mental health digital support system.
She also has a background in consulting from PA Consulting and brings strategic and brand-building capabilities to HN.
Harris was previously chief executive of LHG, an NHS England Multispecialty Community Provider Vanguard organisation, and the largest primary care general practice partnership in the NHS.
He also served as NHS England’s National director of strategy and advised ministers on health policy and strategy.
Cook said: “I’m very excited to have joined HN at this crucial time in the company’s development and at this critical juncture for healthcare delivery in the UK.
“HN’s unique application of advanced data science and AI for screening high-need, high-cost patients, combined with its clinical coaching programme, represents a huge opportunity to support patients to be treated and cared for in the right place, at the right time.”
Harris adds: “There are many health tech businesses in the start-up/scale-up stage, but few enjoy HN’s potential.
“Already an award-winning company with a proven track record, I believe HN can become a major provider of population health management solutions.
“There are very few companies that I’m asked to work with that truly have the potential to tackle some of healthcare’s biggest challenges, and HN is undoubtedly one of them.”